Oxford Vaccine Partner Plans Trials In India, Manufacturing Soon | Read

PUBLISHED ON: July 21, 2020 | Duration: 1 min, 35 sec

  
loading..
Trials for the coronavirus vaccine developed at the Oxford University will begin in India as soon as a license is procured, said the Indian firm partnering the researchers in the UK. The vaccine AZD1222 had a favourable response in the first phase of clinical trials. It did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal.
ALSO WATCH
Centre Rejects Volunteer's Claim, Clears Oxford Vaccine Trials In India

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com